Table 1 TSQM Validation Survey: Respondent Characteristics (n = 567)
Illness Group | Major Route of Admin: Total (%) | Weeks on Medication Mean (SD) | Health Rating+ Mean (SD) | Illness Severity++ Mean (SD) |
|---|---|---|---|---|
Migraine (n = 68) | Oral: 60 (88.2%) | 57.2 (76.4) | 2.8 (.8) | 1.9 (.6) |
Arthritis (n = 75) | Oral: 71 (94.7%) | 38.2 (40.4) | 2.9 (.9) | 1.9 (.6) |
High BP (n = 76) | Oral: 76 (100%) | 52.1 (53.2) | 2.5 (.8) | 1.7 (.6) |
Asthma (n = 72) | Inhaled: 62(86.1%) | 92.4 (114.8) | 2.9 (1.0) | 1.8 (.7) |
Diabetes (n = 63) | Injected: 53 (84.1%) | 125.0 (115.4) | 3.4 (.9) | 2.2 (.5) |
Psoriasis (n = 63) | Topical: 53 (84.1%) | 49.7 (60.1) | 2.9 (.9) | 1.7 (.6) |
High Cholesterol (n = 75) | Oral: 75 (100%) | 31.0 (34.7) | 2.8 (1.0) | 2.0 (.6) |
Depression (n = 75) | Oral: 75 (100%) | 42.9 (42.7) | 2.6 (.9) | 2.1 (.5) |